Raymond James Financial Services Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,131
Closed -$552K 3369
2023
Q3
$552K Sell
10,131
-735
-7% -$43.6K ﹤0.01% 2267
2023
Q2
$731K Hold
10,866
﹤0.01% 2109
2023
Q1
$559K Sell
10,866
-424
-4% -$20.6K ﹤0.01% 2262
2022
Q4
$520K Sell
11,290
-2,569
-19% -$120K ﹤0.01% 2239
2022
Q3
$702K Buy
13,859
+1,405
+11% +$70.2K ﹤0.01% 2052
2022
Q2
$567K Sell
12,454
-836
-6% -$37.4K ﹤0.01% 2187
2022
Q1
$618K Hold
13,290
﹤0.01% 2248
2021
Q4
$668K Sell
13,290
-75
-0.6% -$3.88K ﹤0.01% 2204
2021
Q3
$710K Sell
13,365
-89
-0.7% -$5.01K ﹤0.01% 2159
2021
Q2
$821K Buy
13,454
+196
+1% +$10.4K ﹤0.01% 2077
2021
Q1
$647K Buy
13,258
+2
+0% +$94 ﹤0.01% 2121
2020
Q4
$537K Buy
13,256
+194
+1% +$6.93K ﹤0.01% 2098
2020
Q3
$425K Sell
13,062
-939
-7% -$28.2K ﹤0.01% 2074
2020
Q2
$370K Buy
+14,001
New +$366K ﹤0.01% 2113
2020
Q1
Sell
-14,722
Closed -$529K 2676
2019
Q4
$529K Sell
14,722
-3,190
-18% -$110K ﹤0.01% 1941
2019
Q3
$612K Hold
17,912
﹤0.01% 1773
2019
Q2
$501K Sell
17,912
-1,405
-7% -$39K ﹤0.01% 1932
2019
Q1
$599K Sell
19,317
-1,409
-7% -$37.6K ﹤0.01% 1772
2018
Q4
$490K Buy
20,726
+480
+2% +$13.1K ﹤0.01% 1682
2018
Q3
$784K Buy
20,246
+580
+3% +$20.9K ﹤0.01% 1626
2018
Q2
$658K Buy
+19,666
New +$700K ﹤0.01% 1688
2018
Q1
Sell
-10,109
Closed -$322K 2655
2017
Q4
$322K Buy
+10,109
New +$346K ﹤0.01% 1979

Other funds holding LMAT

Raymond James Financial Services Advisors's LMAT Position: Q4 2023 in Review

Raymond James Financial Services Advisors sold out of LeMaitre Vascular (LMAT) in Q4 2023, closing a stake of 10,131 shares — an estimated $552K sold.

Raymond James Financial Services Advisors first reported a position in LMAT in Q4 2017 and held it in 22 quarters. The position peaked at $821K in Q2 2021. 227 funds tracked by Wall St. Rank hold LMAT as of Q4 2023.

  • Raymond James Financial Services Advisors reported no remaining LeMaitre Vascular position as of Q4 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 10,131 LeMaitre Vascular shares in Q4 2023, an estimated $552K.
  • Raymond James Financial Services Advisors first reported a position in LeMaitre Vascular in Q4 2017 and held it in 22 quarters.
  • Raymond James Financial Services Advisors's LeMaitre Vascular position peaked at $821K in Q2 2021.
  • 227 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.